Japan's Takeda considers possible $40 bln bid for Shire

ReutersNewsPublished: March 28, 2018
Published: March 28, 2018

Japan's largest drugmaker Takeda Pharmaceutical is considering a bid for London-listed Shire that could top $40 billion and spark another takeover battle in the deal-hungry pharma industry. David Pollard reports.

Be the first to suggest a tag

    Comments

    0 comments